← Back
Data updated: Mar 10, 2026
ANTARES PHARMA INC
Gastroenterology
ANTARES PHARMA INC is a pharmaceutical company focused on Gastroenterology. Key products include XYOSTED (AUTOINJECTOR).
2015
Since
2
Drugs
-
Trials
12
Approved (2yr)
Recent Activity
SUMATRIPTAN SUCCINATE 2025-11-06
SUMATRIPTAN SUCCINATE 2025-10-21
Labeling
SUMATRIPTAN SUCCINATE 2025-07-25
Labeling
SUMATRIPTAN SUCCINATE 2025-07-15
XYOSTED (AUTOINJECTOR) 2025-07-11
Labeling
SUMATRIPTAN SUCCINATE 2025-03-28
Manufacturing (CMC)
SUMATRIPTAN SUCCINATE 2025-03-17
Manufacturing (CMC)
SUMATRIPTAN SUCCINATE 2024-12-31
SUMATRIPTAN SUCCINATE 2024-12-12
Labeling
SUMATRIPTAN SUCCINATE 2024-12-12
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 100%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- 2015-12-10
- Latest
- 2025-07-11
- Applications
- 2